UChicago Medicine, NewcelX Ltd., and Eledon Pharmaceuticals provided data supporting current type 1 diabetes research and are seeking FIH trial approval for stem cell therapy under FDA clearance.
1 report, 1 independent
Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
UChicago Medicine, NewcelX Ltd., and Eledon Pharmaceuticals provided data supporting current type 1 diabetes research and are seeking FIH trial approval for stem cell therapy under FDA clearance.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Nature Cell acquired a stem cell manufacturing facility and is seeking BLA filing for its stem cell therapy.Sub-event
UChicago Medicine, NewcelX Ltd., and Eledon Pharmaceuticals provided data supporting current type 1 diabetes research and are seeking FIH trial approval for stem cell therapy under FDA clearance.1 source
Keep exploring
The entities involved
-
UChicago Medicine
American medical network (2006-)
Nothing else this week.
- FDA